Predictive value of prothrombin G20210A mutation detection in pulmonary thromboembolism
10.13481/j.1671-587x.20140533
- VernacularTitle:凝血酶原基因G20210A突变检测对肺血栓栓塞症的预测价值
- Author:
Jia ZHANG
;
Fengqin ZHAO
;
Ping TAN
;
Hong JI
- Publication Type:Journal Article
- Keywords:
pulmonary thromboembolism;
G20210A gene;
prothrombin
- From:
Journal of Jilin University(Medicine Edition)
2014;(5):1080-1084
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the incidence frequency of prothrombin G20210A (FⅡ G20210A)mutation in the patients with pulmonary thromboembolism(PTE)in northeast China,and to clarify the predictive value of FⅡG20210A mutation detection in PTE of the population in northeast China.Methods 60 PTE patients(PTE group) and 80 sex-matched healthy controls(control group)from the same geographic area were selected.All the patients were diagnosed by lung ventilation/perfusion scan and/or multi-slice CT pulmonary angiography(CTPA)as well as medical history.The genome DNA was extracted from the whole blood using alcohol.Polymerase chain reaction (PCR),restriction fragment length polymorphisms(RFLP)analysis with HindⅢ restriction enzyme and sepharose gel electrophoresis were used to identify the F Ⅱ G20210A mutation in PTE group and control group. Results After digested by HindⅢ restriction enzyme,only the fragments of 407 and 99 bp were found in PTE group.The frequency of FⅡ G20210A mutation was 0%,there was no statistical difference compared with contol group(P>0.05).There were no heterozygote and homozygote mutation of FⅡ G202210A gene in PTE group and control group.Conclusion The incidence of FⅡ G20210A mutation in the PTE patients in northeast China is very low,and the detection of FⅡ G20210A mutation may have no predictive value in PTE of the population in northeast China.
